Yes @Cornhulio at least the Starpharma announcements are consistent - always touting the tantalising potentialbillion dollar revenues while at the same time promoting results from their pre-clinical studies that are many years away from commercialisation IF the results are even replicated in human trials ?
..... and of course let's not forget the infamous references to "discussions with potential partners" ... Roche and Gennentech are also mentioned numerous times throughout the announcement but obviously there has been no commitment from them to date ? The Genentech research agreement was originally signed in 2021 .... classic Starpharma
Starpharma is planning to conduct clinical testing of DEP® HER2-zirconium and other DEP® radiotheranostics and is also engaging in discussions with potential partners in this area.
The market wants readouts / results ?
Where are the long awaited in house DEP phase 2 trial results ?
Where are the Viraleze UK after market COVID-19 study results ?
SPL Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
